Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Effectiveness Study of Combo Bio-engineered Sirolimus Eluting Stent (REMEDEE)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
OrbusNeich
ClinicalTrials.gov Identifier:
NCT00967902
First received: August 26, 2009
Last updated: December 11, 2013
Last verified: December 2013